e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation
Anton Conrad, Sabina Janciauskiene, Thomas Köhnlein, Jan Fuge, Philipp Ivanyi, Igor Tudorache, Jens Gottlieb, Tobias Welte, Thomas Fuehner
Source:
Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anton Conrad, Sabina Janciauskiene, Thomas Köhnlein, Jan Fuge, Philipp Ivanyi, Igor Tudorache, Jens Gottlieb, Tobias Welte, Thomas Fuehner. Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation. Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Transplantation pulmonaire à l’heure de la médecine de précision Lung transplantation in the era of precision medicine
Lung transplantation
Related content which might interest you:
The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients
Source: Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019
Year: 2019
Long-term experience in the treatment of alpha 1-antitrypsin deficiency: 25 years of augmentation therapy
Source: Eur Respir Rev 2015; 24: 46-51
Year: 2015
Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Outcomes and survival in alpha1-antitrypsin deficiency post lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Homecare setting of longterm augmentation therapy in alpha1 antitrypsin defiency patients leads to clinical stabilization
Source: International Congress 2017 – New frontiers in home care management of chronic lung diseases
Year: 2017
Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Effect of augmentation therapy on immune function of patients with severe Alpha1-antitrypsin deficiency
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
Long-term effect of alpha-1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough
Source: Eur Respir J 2016; 47: 35-38
Year: 2016
Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007
Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Lung transplantation of ventilator-dependent patients - analysis of survival and graft function in 27 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001
Lung transplantation in alpha 1 antitrypsin deficiency
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Predictors of survival of patients waiting for lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003
Effect of enzyme replacement therapy (ERT) on lung involvement and changes of different peripheral blood T-cell subsets in Fabry disease patients
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept